Delivery Order SPE2DB20D3101-SPE2DB23FQYV4
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $3,681.08, is a delivery order for 4562560501 - POSACONAZOLE DR 100 MG TABLET 60S. It is a firm fixed-price contract with an ultimate completion date of October 24, 2023. The contract was awarded on October 23, 2023, and there was no set-aside designation used. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and...
- This federal contract award is for the delivery of 4,562,841,818 units of POSACONAZOLE DR 100 MG TABLET 60S to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $29,449.54 and is a firm fixed price delivery order. The contract has no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,839.27 firm fixed-price delivery order covers the supply of POSACONAZOLE DR 100 MG TABLET UD 20S, a pharmaceutical product, with a performance period through January 27, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,676.82 Firm Fixed Price delivery order is for POSACONAZOLE DR 100 MG TABLET 60S, a medication, with a period of performance ending on June 12, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) designated as SPE2DX that Amerisourcebergen holds with DLA...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract, valued at $2,074.64, is for the delivery of POSACONAZOLE DR 100 MG TABLET 60S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The...
- This federal contract award, with ID SPE2DB20D3103|SPE2DB24FM1A8, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,163.68 firm fixed-price delivery order is for the supply of 4,563,201,952 tablets of Posaconazole delayed-release 100mg. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4568700372 Posaconazole DR 100 mg Tablet 60s, a pharmaceutical product. The contract has a ceiling value of $3,073.39 and is a firm fixed price delivery order. The contract has an ultimate completion date of July 3, 2025. This contract is not set-aside and is open to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 4,562,216,202 units of POSACONAZOLE DR 100 MG Tablets in 60-count packages. The $4,139.21 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, on September 18, 2022, with a completion date of September 19, 2023. This contract award is not designated as a set-aside. The award is associated with a larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,856,840 POSACONAZOLE DR 100 MG TABLET 60S. The $2,502.07 delivery order was awarded on April 11, 2022 with a completion date of April 12, 2022. Amerisourcebergen Drug Corp provides pharmaceutical products and services to U.S. government agencies, including the Department of Defense, and has an indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,567.58 to AmerisourceBergen Drug Corp for the supply of Posaconazole DR 100 mg tablets (60-count). This competitive award, issued on September 16, 2025, with an ultimate completion date of September 17, 2025, utilizes firm fixed pricing and carries no set-aside designation. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters....
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB23FQYV4Delivery Order
This federal contract award, with ID SPE2DB20D3101|SPE2DB23FQYV4, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $4,644.30, is for the delivery of the pharmaceutical product POSACONAZOLE DR 100 MG TABLET 60S. The contract has an ultimate completion date of January 4, 2023 and is structured as a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 1/3/23 |